Related Experiment Video

Updated: Jan 22, 2026

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
07:10

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

Published on: June 18, 2020

22.5K

Retrospective Analysis of Chronic Hepatitis C Patients with Hepatic Iron Depletion

Hassan A Aziz1

  • 1Department of Clinical Laboratory Sciences, College of Health Professions, University Of Tennessee Health Science Center, Memphis, TN, USA habdelaz@uthsc.edu.

Annals of Clinical and Laboratory Science
|July 17, 2019
PubMed

Insights

Chronic hepatitis C patients often develop iron deficiency. While iron markers may decrease during treatment, this can support improved therapeutic responses in managing hepatitis C.

Area of Science:

  • Hepatology
  • Internal Medicine
  • Biochemistry

Background:

  • Chronic hepatitis C (HCV) infection is a significant global health concern.
  • Hepatic iron accumulation is a known factor influencing liver disease progression and treatment outcomes in HCV.
  • Understanding the role of iron metabolism is crucial for optimizing hepatitis C therapy.

Purpose of the Study:

  • To retrospectively analyze the impact of hepatic iron depletion on the treatment efficacy in patients with chronic hepatitis C.
  • To investigate the relationship between iron markers and treatment response in chronic hepatitis C.
  • To evaluate the clinical significance of iron deficiency in the management of hepatitis C.

Main Methods:

  • Retrospective analysis of 195 chronic hepatitis C patients from Hamad General Hospital.
  • Biochemical assessment including Aspartate aminotransferase (AST), Alanine aminotransferase (ALT), and gamma-glutamyl transferase (GGT) levels.
  • Statistical analysis involving descriptive statistics and mean testing to evaluate data trends.

Main Results:

  • Ferritin levels showed a positive correlation with HCV, though not statistically significant (R=0.450, p=0.182).
  • Alanine aminotransferase (ALT) and gamma-glutamyl transferase (GGT) levels exhibited slight increases during treatment (p-values > 0.05).
  • Chronic hepatitis C patients demonstrated a tendency towards iron deficiency, identifiable through various iron markers.

Conclusions:

  • Iron markers may significantly decrease in hepatitis C patients undergoing treatment.
  • The observed decrease in iron markers is considered supportive of treatment management strategies.
  • Further research is warranted to fully elucidate the role of iron depletion in improving treatment response for hepatitis C.
Abstract

Keywords:
Chronic HepatitisHepatic SystemPathological Condition

More Related Videos

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

16.8K
Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma09:52

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

13.9K

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
261
Hepatic Portal System01:21

Hepatic Portal System

The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
5.6K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
219
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
539
Hepatic Drug Clearance: Role of Transporters01:14

Hepatic Drug Clearance: Role of Transporters

In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
304
Hepatic Drug Excretion: Enterohepatic Cycling01:17

Hepatic Drug Excretion: Enterohepatic Cycling

Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
2.7K